107916-92-7 Usage
Uses
Used in Pharmaceutical Research:
AKOS B018336 is used as a research compound for investigating its potential therapeutic effects on various health conditions, including diabetes, cancer, and inflammation. Its strong inhibitory effects on trypsin make it a valuable tool in drug discovery and development.
Used in Drug Development:
AKOS B018336 is used as a potential drug candidate for treating various health conditions due to its therapeutic properties and strong inhibitory effects on trypsin. Its unique chemical structure and properties contribute to its potential as a novel therapeutic agent.
Used in Enzyme Inhibition Studies:
AKOS B018336 is used as an enzyme inhibitor in studies focusing on the role of trypsin in various biological processes. Its strong inhibitory effects on trypsin make it a valuable tool for understanding the enzyme's function and potential therapeutic applications.
Used in Medical Research:
AKOS B018336 is used as a research compound in medical studies to explore its potential role in treating various health conditions. Its therapeutic properties and strong inhibitory effects on trypsin make it a promising candidate for further research and development in the medical field.
Check Digit Verification of cas no
The CAS Registry Mumber 107916-92-7 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 1,0,7,9,1 and 6 respectively; the second part has 2 digits, 9 and 2 respectively.
Calculate Digit Verification of CAS Registry Number 107916-92:
(8*1)+(7*0)+(6*7)+(5*9)+(4*1)+(3*6)+(2*9)+(1*2)=137
137 % 10 = 7
So 107916-92-7 is a valid CAS Registry Number.
InChI:InChI=1/C14H9NOS2/c16-13-12(18-14(17)15-13)8-9-5-6-10-3-1-2-4-11(10)7-9/h1-8H,(H,15,16,17)/b12-8+
107916-92-7Relevant academic research and scientific papers
5-Benzylidenerhodanine and 5-benzylidene-2-4-thiazolidinedione based antibacterials
Zvarec, Ondrej,Polyak, Steven W.,Tieu, William,Kuan, Kevin,Dai, Huanqin,Pedersen, Daniel Sejer,Morona, Renato,Zhang, Lixin,Booker, Grant W.,Abell, Andrew D.
experimental part, p. 2720 - 2722 (2012/05/31)
Herein we outline the antibacterial activity of amino acid containing thiazolidinediones and rhodanines against Gram-positive bacteria Staphylococcus aureus ATCC 31890, Staphylococcus epidermidis and Bacillus subtilis ATCC 6633. The rhodanine derivatives
